Abstract
To provide nurse practitioners with the information to manage patients with chronic hepatitis C (HCV) receiving a new combination drug therapy containing ribavirin and interferon alfa-2b. Reviews of clinical trial results including large multicenter trials, Centers for Disease Control and Prevention documents, data from the drug manufacturer. This new therapy offers the potential for HCV remission or complete cure of the HCV infection. Although virologic responses are markedly improved with combination therapy, the side effects associated with combination therapy warrant regular patient monitoring, management, and medical intervention when clinically indicated. Combination therapy does not significantly worsen the side effects associated with mono-therapy, which are predictable, manageable, and reversible. However, proper patient education, symptom management, vigilance for serious side effects, and monitoring of hematologic parameters are critical to patient outcome.
References
Jan 1, 1979·Pharmacology & Therapeutics·R W SidwellI W Hillyard
Feb 1, 1978·Teratology·V H FermL Kilham
Dec 31, 1992·The New England Journal of Medicine·L B SeeffR P Perrillo
Sep 1, 1992·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·A M Di BisceglieJ H Hoofnagle
Jul 11, 1991·The New England Journal of Medicine·P FarciR H Purcell
Aug 25, 1972·Science·R W SidwellR K Robins
Aug 25, 1972·Science·R S Berger
Jan 1, 1984·Antimicrobial Agents and Chemotherapy·F G HaydenN L Pushkarskaya
Jan 1, 1980·Toxicology and Applied Pharmacology·D M KochharT B Knudsen
Feb 1, 1995·Seminars in Liver Disease·M J Alter
Jun 1, 1995·The New England Journal of Medicine·T PoynardJ M Costa
Jun 27, 1996·The New England Journal of Medicine·G B SchreiberJ J Korelitz
Jun 27, 1996·The New England Journal of Medicine·C Conry-CantilenaJ W Shih
Jun 1, 1996·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·M YanoK Okuda
Nov 1, 1996·Journal of Viral Hepatitis·P ColombattoM R Brunetto
Feb 1, 1997·Gastroenterology·G FattovichG Realdi
Jan 1, 1997·Tissue Antigens·I RumbaC B Sanjeevi
Mar 22, 1997·Lancet·T PoynardP Opolon
May 1, 1997·Gastroenterology·G García-Tsao
Jan 1, 1997·Journal of Hepatology·A C AnandJ M Neuberger
Aug 1, 1997·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·H C BodenheimerL B Seeff
Sep 1, 1997·Gastroenterology·L Mayer
Sep 26, 1997·Hepatology : Official Journal of the American Association for the Study of Liver Diseases
Sep 26, 1997·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·J E EverhartJ H Hoofnagle
Sep 26, 1997·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·G Dusheiko
Sep 26, 1997·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·A AlbertiG De Salvo
Nov 14, 1997·Gastroenterology·L ChemelloA Alberti
Jul 22, 1998·Journal of Hepatology·J T BrouwerS W Schalm
Nov 10, 1998·Lancet·T PoynardJ Albrecht
Nov 20, 1998·The New England Journal of Medicine·J G McHutchisonJ K Albrecht
Nov 20, 1998·The New England Journal of Medicine·G L DavisJ Albrecht
Citations
Nov 9, 2002·Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·Ashok B JainJohn J Fung
Sep 16, 2006·Gastroenterology Nursing : the Official Journal of the Society of Gastroenterology Nurses and Associates·Kate Sheppard, Ann Hubbert
Jun 18, 2010·The Nurse Practitioner·Christine S Brennan
Oct 13, 2009·Gastroenterology Nursing : the Official Journal of the Society of Gastroenterology Nurses and Associates·Tracy M Christianson, Donna Moralejo
Oct 24, 2003·The Journal of the Association of Nurses in AIDS Care : JANAC·Richard S Ferri, Carl A Kirton
Dec 6, 2007·Alimentary Pharmacology & Therapeutics·R S Brown
Sep 18, 2010·Journal of Clinical Nursing·Anne Grogan, Fiona Timmins
Jan 22, 2010·The Cochrane Database of Systematic Reviews·Jesper BrokChristian Gluud